Ignite Creation Date:
2024-05-05 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00085761
Status:
TERMINATED
Last Update Posted:
2008-03-06
First Post:
2004-06-14
Brief Title:
Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy
Sponsor:
NeurogesX
Organization:
NeurogesX
Study Overview
Official Title:
An International Multicenter Randomized Double-Blind 12-Week Controlled Study of NGX-4010 for Treatment of Painful HIV-Associated Neuropathy
Status:
TERMINATED
Status Verified Date:
2008-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Terminated in view of the C107 findings demonstrating efficacy at doses of 90 and 30 minutes
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to determine if an investigational drug NGX-4010 high-concentration capsaicin patch is safe tolerable and effective in treating painful HIV-associated neuropathy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None